↓ Skip to main content

Randomized controlled trial of Hepatitis B virus vaccine in HIV-1-infected patients comparing two different doses

Overview of attention for article published in AIDS Research and Therapy, April 2006
Altmetric Badge

Mentioned by

policy
1 policy source

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Randomized controlled trial of Hepatitis B virus vaccine in HIV-1-infected patients comparing two different doses
Published in
AIDS Research and Therapy, April 2006
DOI 10.1186/1742-6405-3-9
Pubmed ID
Authors

Patricia Cornejo-Juárez, Patricia Volkow-Fernández, Kenia Escobedo-López, Diana Vilar-Compte, Guillermo Ruiz-Palacios, Luis Enrique Soto-Ramírez

Abstract

Co-infection with hepatitis B virus (HBV) and human immunodeficiency virus (HIV) is not infrequent as both share same route of exposure. The risk of developing chronic hepatitis B virus is 6%, in general population but can reach 10-20% in HBV/HIV co-infected patients. When compared to general population, the response rate to HBV vaccine in HIV-infected patients is diminished, so previous studies have tried to improve this response using variety of schedules, doses and co-administration of immunomodulators. The purpose of this study was to evaluate two doses of recombinant HBV vaccine (10 or 40 microg), IM at 0, 1 and 6 months. Vaccination response was measured 30-50 days after last dose; titers of >9.9 IU/L were considered positive.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 4%
Unknown 23 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 25%
Researcher 4 17%
Student > Ph. D. Student 3 13%
Student > Bachelor 2 8%
Professor 2 8%
Other 5 21%
Unknown 2 8%
Readers by discipline Count As %
Medicine and Dentistry 14 58%
Biochemistry, Genetics and Molecular Biology 2 8%
Immunology and Microbiology 2 8%
Agricultural and Biological Sciences 1 4%
Decision Sciences 1 4%
Other 1 4%
Unknown 3 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 June 2012.
All research outputs
#7,447,868
of 22,769,322 outputs
Outputs from AIDS Research and Therapy
#201
of 549 outputs
Outputs of similar age
#23,314
of 66,395 outputs
Outputs of similar age from AIDS Research and Therapy
#2
of 3 outputs
Altmetric has tracked 22,769,322 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 549 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 66,395 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.